STOCK TITAN

Integer Hldgs Corp SEC Filings

ITGR NYSE

Welcome to our dedicated page for Integer Hldgs SEC filings (Ticker: ITGR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Device engineers know that building a pacemaker lead is painstaking; reading the filings of the company that makes it can be just as exacting. Integer Holdings’ 10-K spans intricate disclosures on cardiac rhythm management, neuromodulation, and sterile manufacturing lines, creating a maze for anyone hunting key numbers or insider moves. If you have ever typed “Integer Holdings SEC filings explained simply” or wanted the cardiac segment margin without scrolling through 250 pages, you have felt the problem.

Stock Titan delivers the solution. Our platform ingests every submission the moment it hits EDGAR and converts legal jargon into plain language with AI-powered summaries. Want “Integer Holdings quarterly earnings report 10-Q filing” insights? Need “Integer Holdings insider trading Form 4 transactions” in real time? Looking for the specific 8-K that details a new sterilization line? Find them fast, plus concise explanations of why they matter. Key sections are surfaced automatically so you can:

  • Track “Integer Holdings executive stock transactions Form 4” before material events
  • Compare backlog growth across divisions using “Integer Holdings earnings report filing analysis”
  • Spot pay structures in the “Integer Holdings proxy statement executive compensation”

Whether you are understanding Integer Holdings SEC documents with AI for compliance checks or modelling forecasts, every 10-K, 10-Q, 8-K material event, and “Integer Holdings annual report 10-K simplified” summary is here—updated continuously, searchable instantly, and interpreted clearly. Save hours, avoid missed details, and make confident decisions with the only page that links Integer’s precision manufacturing story to the numbers behind it.

Rhea-AI Summary

Arhaus, Inc. (NASDAQ: ARHS) filed an 8-K announcing a board change. On 27 June 2025 the Board appointed Samir Desai—currently EVP & Chief Digital and Technology Officer at Abercrombie & Fitch—as an independent Class III director. His initial term runs until the 2027 annual meeting, after which he is expected to stand for re-election. Desai will sit on the Board’s Technology Committee, bringing extensive omnichannel retail and IT leadership experience from Abercrombie & Fitch, Equinox Group and Intertex Apparel Group. To accommodate the appointment, the Board’s size rises from ten to eleven directors. Compensation will mirror that of Arhaus’s other non-employee directors and no related-party transactions were reported. Exhibit 104 (Inline XBRL cover page) accompanies the filing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.16%
Tags
current report

FAQ

What is the current stock price of Integer Hldgs (ITGR)?

The current stock price of Integer Hldgs (ITGR) is $121 as of July 3, 2025.

What is the market cap of Integer Hldgs (ITGR)?

The market cap of Integer Hldgs (ITGR) is approximately 4.3B.

What is the core business of Integer Holdings Corporation?

Integer specializes in contract development and manufacturing of medical device components, serving markets like cardiac rhythm management, neuromodulation, and cardio & vascular.

How does Integer generate its revenue?

The company generates revenue through long-term service contracts, manufacturing agreements with OEMs, and strategic partnerships that support design, development, and production of medical devices.

What distinguishes Integer from its competitors?

Integer stands out by combining advanced manufacturing capabilities with deep industry expertise, a robust quality management system, and a comprehensive end-to-end service model tailored to medtech companies.

What are the primary product segments served by Integer?

Integer primarily serves the Cardio & Vascular segment, Cardiac Rhythm Management & Neuromodulation segment, along with other specialized medical markets.

What role does research and development play at Integer?

R&D is central to Integer's strategy, enabling rapid prototyping and the seamless integration of innovative technologies into its manufacturing processes, ultimately reducing time-to-market for new therapies.

How has Integer's strategic focus evolved?

Historically diversified with a non-medical battery segment, Integer has realigned its strategy by divesting non-core businesses to become a pure-play medtech company, honing its focus on high-quality medical manufacturing.

Why is quality and regulatory compliance important to Integer?

Quality and regulatory compliance are critical as they ensure the safety and efficacy of medical devices. Integer invests heavily in these areas to meet stringent industry standards and support patient safety.

How does Integer support its global customer base?

With a network of advanced manufacturing facilities and strategic investments in regions like Ireland, Integer is well-positioned to serve both local and international markets with innovative, reliable technology solutions.
Integer Hldgs Corp

NYSE:ITGR

ITGR Rankings

ITGR Stock Data

4.25B
33.89M
1.85%
121.18%
6.6%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
PLANO